Danaher Completes Acquisition of Abcam

Rhea-AI Summary

Danaher Corporation (NYSE:DHR) has completed the acquisition of Abcam plc (NASDAQ:ABCM) for $24.00 per share in cash, making Abcam an indirect wholly owned subsidiary of Danaher. Trading of Abcam ADSs on Nasdaq has been suspended.

WASHINGTON, Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam").

The acquisition of Abcam for $24.00 per share in cash was implemented by way of a Court-sanctioned scheme of arrangement under the UK Companies Act 2006 (the "Scheme") and the Scheme became effective in accordance with its terms on December 6, 2023. As a result, Abcam has become an indirect wholly owned subsidiary of Danaher. Trading of Abcam ADSs on Nasdaq has been suspended.

The consideration due to former Abcam shareholders will be settled pursuant to the terms of the Scheme and the consideration due to former Abcam ADS holders will be settled by the Depositary pursuant to the terms of the Deposit Agreement, in each case as further described in the shareholder circular relating to the Scheme, which was published by Abcam on October 5, 2023.

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 65,000+ associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860

View original content:https://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-abcam-302007456.html

SOURCE Danaher Corporation

FAQ

What is the latest acquisition by Danaher Corporation (NYSE:DHR)?

The latest acquisition by Danaher Corporation (NYSE:DHR) is the completion of the acquisition of Abcam plc (NASDAQ:ABCM) for $24.00 per share in cash.

How was the acquisition of Abcam plc (NASDAQ:ABCM) implemented?

The acquisition of Abcam plc (NASDAQ:ABCM) was implemented by way of a Court-sanctioned scheme of arrangement under the UK Companies Act 2006.

What is the status of Abcam plc (NASDAQ:ABCM) after the acquisition by Danaher Corporation (NYSE:DHR)?

Abcam plc (NASDAQ:ABCM) has become an indirect wholly owned subsidiary of Danaher Corporation (NYSE:DHR) as a result of the acquisition.

What is the settlement process for former Abcam shareholders and ADS holders after the acquisition?

The consideration due to former Abcam shareholders will be settled pursuant to the terms of the Scheme, and the consideration due to former Abcam ADS holders will be settled by the Depositary pursuant to the terms of the Deposit Agreement.